Table 1 Patient and tumor characteristics
Group A | Group B | Group C | Total | |
|---|---|---|---|---|
Factor | 66 Gy | > 66 Gy < 70 Gy | ≥ 70 Gy | |
n =23 (%) | n = 15 (%) | n = 38 (%) | N = 76 (%) | |
Age: | ||||
< 60 years | 10(43.5) | 4(26.7) | 10(26.3) | 24(31.6) |
≥ 60 years | 13(56.5) | 11(73.3) | 28(73.7) | 52(68.4) |
Median | 63 | |||
Preoperative PSA: | ||||
≤ 10 ng/ml | 10(43.5) | 9(60) | 22(57.9) | 41(53.9) |
>10 ng/ml ≤ 20 ng/ml | 7(30.4) | 4(26.7) | 10(26.3) | 21(27.7) |
> 20 ng/ml | 2(8.7) | 0(0) | 4(10.5) | 6(7.9) |
Missing | 4(17.4) | 2(13.3) | 2(5.3) | 8(10.5) |
Median | 7,9 | |||
Tumor size: | ||||
pT2 | 8(34.8) | 9(60) | 19(50) | 36(47.3) |
pT3a | 8(34.8) | 3(20) | 12(31.6) | 23(30.3) |
pT3b | 6(26.1) | 3(20) | 7(18.4) | 16(21.1) |
Missing | 1(4.3) | 0(0) | 0(0) | 1(1.3) |
Gleason score: | ||||
≤ 6 | 4(17.4) | 1(6.7) | 2(5.3) | 7(9.2) |
7 | 13(56.6) | 9(60) | 23(60.5) | 45(59.2) |
≥ 8 | 5(21.7) | 5(33.3) | 13(34.2) | 23(30.3) |
Missing | 1(4.3) | 0(0) | 0(0) | 1(1.3) |
Surgical margin: | ||||
R1 | 9(39.1) | 5(33.3) | 17(44.7) | 31(40.7) |
Rx (close) | 4(17.4) | 3(20) | 9(23.7) | 16(21.1) |
R0 | 8(34.8) | 7(46.7) | 10(26.3) | 25(32.9) |
Missing | 2(8.7) | 0(0) | 2(5.3) | 4(5.3) |
Risk groups: | ||||
High | 17(73.9) | 13(86.7) | 33(86.8) | 63(82.9) |
Intermediate | 6(26.1) | 2(13.3) | 5(13.2) | 13(17.1) |
Pre-irradiation PSA: | ||||
≤ 0.5 ng/ml | 15(65.2) | 9(60) | 22(57.9) | 46(60.5) |
> 0.5 ng/ml | 8(34.8) | 6(40) | 16(42.1) | 30(39.5) |
Median | 0,5 | |||
Evidence of local recurrence | ||||
Yes | 2(8.7) | 2(13.3) | 17(44.7) | 21(27.6) |
No | 21(91.3) | 13(86.7) | 21(55.3) | 55(72.4) |